We are live on
!
Find out more
GLRA
Gerald L. Ray & Associates Portfolio holdings
AUM
$802M
1-Year Est. Return
21.01%
This Fund
S&P 500
This Quarter
Est. Return
+2.9%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$447M
AUM Growth
–
Cap. Flow
+$452M
Cap. Flow
% of AUM
101.18%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
260
New
260
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$16.4M |
| 2 |
CELG
Celgene Corp
CELG
|
+$16.3M |
| 3 |
Amgen
AMGN
|
+$12.9M |
| 4 |
Southwest Airlines
LUV
|
+$12.3M |
| 5 |
Apple
AAPL
|
+$10.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.33% |
| 2 | Consumer Staples | 13.46% |
| 3 | Industrials | 12.37% |
| 4 | Energy | 9.97% |
| 5 | Technology | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Caterpillar
CAT
$409B
| $4.91M | 1.1% |
+59,509
| New | +$5.06M |
|
27
Pfizer
PFE
$140B
| $4.87M | 1.09% |
+183,418
| New | +$5.07M |
|
28
Walt Disney
DIS
$165B
| $4.86M | 1.09% |
+76,986
| New | +$4.86M |
|
|
KSU
29
DELISTED
Kansas City Southern
KSU
| $4.76M | 1.07% |
+44,950
| New | +$4.89M |
|
|
MMP
30
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $4.47M | 1% |
+82,012
| New | +$4.3M |
|
31
Cisco
CSCO
$450B
| $4.45M | 1% |
+182,748
| New | +$4.11M |
|
32
Chevron
CVX
$388B
| $4.05M | 0.91% |
+34,213
| New | +$4.14M |
|
33
Microsoft
MSFT
$2.84T
| $3.99M | 0.89% |
+115,450
| New | +$3.78M |
|
34
UnitedHealth
UNH
$382B
| $3.97M | 0.89% |
+60,645
| New | +$3.77M |
|
35
Simon Property Group
SPG
$74.5B
| $3.89M | 0.87% |
+26,205
| New | +$4.2M |
|
36
Vertex Pharmaceuticals
VRTX
$121B
| $3.77M | 0.84% |
+47,070
| New | +$3.47M |
|
37
Goldman Sachs Group Inc Depositary Shares
GS.PRA
$570M
| $3.68M | 0.82% |
+169,742
| New | +$3.91M |
|
38
Under Armour
UAA
$3B
| $3.65M | 0.82% |
+245,949
| New | +$3.56M |
|
39
Boeing
BA
$165B
| $3.64M | 0.81% |
+35,502
| New | +$3.37M |
|
40
Merck
MRK
$324B
| $3.63M | 0.81% |
+82,010
| New | +$3.66M |
|
|
CBL
41
DELISTED
CBL& Associates Properties, Inc.
CBL
| $3.4M | 0.76% |
+158,679
| New | +$3.76M |
|
|
KMP
42
DELISTED
KINDER MORGAN ENER PNTRS L.P.
KMP
| $3.39M | 0.76% |
+39,722
| New | +$3.46M |
|
43
Estee Lauder
EL
$29B
| $2.98M | 0.67% |
+45,234
| New | +$3.09M |
|
44
Thermo Fisher Scientific
TMO
$211B
| $2.88M | 0.64% |
+33,965
| New | +$2.83M |
|
45
Gilead Sciences
GILD
$161B
| $2.82M | 0.63% |
+54,980
| New | +$2.87M |
|
|
ESRX
46
DELISTED
Express Scripts Holding Company
ESRX
| $2.63M | 0.59% |
+42,563
| New | +$2.56M |
|
47
AT&T
T
$165B
| $2.55M | 0.57% |
+95,433
| New | +$2.65M |
|
48
Wells Fargo
WFC
$261B
| $2.39M | 0.54% |
+57,920
| New | +$2.26M |
|
|
OKS
49
DELISTED
Oneok Partners LP
OKS
| $2.37M | 0.53% |
+47,925
| New | +$2.52M |
|
50
Las Vegas Sands
LVS
$30.5B
| $2.37M | 0.53% |
+44,750
| New | +$2.5M |
|
Similar funds
KRC
GS
PAAMCP
B
JPCCM
NBC
NTC
SD
Gerald L. Ray & Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Gerald L. Ray & Associates, which disclosed 260 positions worth $447M. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Regeneron Pharmaceuticals: 70,490 shares worth $15.9M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Consumer Staples and Industrials.
- Gerald L. Ray & Associates's largest Q2 2013 buy was Regeneron Pharmaceuticals: 70,490 shares worth $15.9M.
- Gerald L. Ray & Associates's ten largest holdings make up 25% of its $447M portfolio in Q2 2013.
- Gerald L. Ray & Associates disclosed 260 positions in Q2 2013, its first 13F filing on record.
Based on Gerald L. Ray & Associates's 13F filing for Q2 2013, filed 1 Aug 2013.